WGS Q4 2025 Earnings — GeneDx Holdings Corp. Revenue & Financial Results | Market Cap Arena

WGSGeneDx Holdings Corp.

$3B

Q4 2025 Earnings

Healthcare Medical - Healthcare Information Services

Income Statement

Revenue

$121M+26.5% YoY

Gross Profit

$79M65.2% margin

Operating Income

-$14M-11.3% margin

Net Income

-$18M-14.6% margin

EPS (Diluted)

$-0.59

QoQ Revenue Growth

+3.6%

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$7M

Stock-Based Comp.

$10M

Balance Sheet

Total Assets

$570M

Total Liabilities

$262M

Stockholders' Equity

$308M

Cash & Equivalents

$105M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$121M	$96M	+26.5%
Gross Profit	$79M	$66M	+19.2%
Operating Income	-$14M	$9M	-255.8%
Net Income	-$18M	$5M	-424.9%

Revenue Segments

Diagnostic Test

$118M49%

Diagnostic Test, Third Party Insurance

$101M42%

Diagnostic Test, Institutional Customers

$16M7%

Product and Service, Other

$3M1%

Diagnostic Test, Self Pay

$297,0000%